Ras Effector Pathways Modulate Scatter Factor-Stimulated NF-κB Signaling and Protection Against DNA Damage

S Fan,Q Meng,J,E M Rosen

DOI: https://doi.org/10.1038/sj.onc.1210271

IF: 8.756

2007-01-01

Oncogene

Abstract:Scatter factor (SF) (hepatocyte growth factor) is a pleiotrophic cytokine that accumulates within tumors in vivo and protects tumor cells against cytotoxicity and apoptosis due to DNA damaging agents in vitro . Previous studies have established that SF-mediated cell protection involves antiapoptotic signaling from its receptor (c-Met) to PI3 kinase → c-Akt → Pak1 (p21-activated kinase -1) → NF- κ B (nuclear factor-kappa B). Here, we found that Ras proteins (H-Ras and R-Ras) enhance SF-mediated activation of NF- κ B and protection of DU-145 and MDCK (Madin–Darby canine kidney) cells against the topoisomerase II α inhibitor adriamycin. Studies of Ras effector loop mutants and their downstream effectors suggest that Ras/PI3 kinase and Ras/Raf1 pathways contribute to SF stimulation of NF- κ B signaling and cell protection. Further studies revealed that Raf1 positively regulates the ability of SF to stimulate NF- κ B activity and cell protection. The ability of Raf1 to stimulate NF- κ B activity was not due to the classical Raf1 → MEK1/2 → ERK1/2 pathway. However, we found that a MEK3/6 → p38 pathway contributes to SF-mediated activation of NF- κ B. In contrast, RalA, a target of the Ras/RalGDS pathway negatively regulated the ability of SF to stimulate NF- κ B activity and cell protection. Ras, Raf1 and RalA modulate SF stimulation of NF- κ B activity, in part, by regulating I κ B kinase (IKK)- β kinase activity. These findings suggest that Ras/Raf1/RalA pathways may converge to modulate NF- κ B activation and SF-mediated survival signaling at the IKK complex and/or a kinase upstream of this complex.